Literature DB >> 15143384

[The levels of oxidant and antioxidant in patients with COPD].

Elif Altuntaş1, Teyfik Turgut, Necip Ilhan, Figen Deveci, Hamdi M Muz, Ilhami Celik.   

Abstract

It is determinate that oxidant-antioxidant imbalance is responsible for pathogenesis of chronic obstructive pulmonary disease (COPD) and smoking is playing a part in the pathogenesis. It was aimed to investigate the oxidant-antioxidant imbalance in smokers and pathogenesis of COPD and their relations with lung functions. This study was done prospectively in Firat University Medical Faculty, Department of Chest Diseases. The levels of plasma malonyldialdehyde (MDA), erythrocyte reducted glutathione (GSH) and erythrocyte catalase were studied in 20 patients with COPD, in 20 smokers and in 20 nonsmokers. All of the cases were male. Pulmonary function tests were done to all cases and the predicted values of FEV1, FVC, and FEV1/FVC were measured. The levels of plasma MDA: 1.44 +/- 0.23 nmol/mL, 1.51 +/- 0.27 nmol/mL and 1.29 +/- 0.13 nmol/mL, the levels of erythrocyte GSH: 0.33 +/- 0.13 micromol/g.Hb, 0.34 +/- 0.17 micromol/g.Hb and 0.44 +/- 0.14 micromol/g.Hb and the levels of catalase were 22.82 +/- 17.47 k/g.Hb, 32.88 +/- 22.36 k/g.Hb and 55.73 +/- 26.56 k/g.Hb in patients with COPD, smokers and healthy nonsmokers respectively. There was no significance in each three parameters between smokers and patients with COPD. A significant difference was observed in each three parameters between nonsmokers and patients with COPD (MDA: p= 0.001, GSH: p= 0.028 and catalase: p< 0.001) and between smokers and nonsmokers (MDA: p= 0.035, GSH: p= 0.016 and catalase: p= 0.005). In all three groups, no significant correlation was found between FEV1 (predicted %), FEV1/FVC (predicted %) and the values of erythrocyte catalase, GSH and plasma MDA. In this study, there was an oxidant-antioxidant imbalance systemically in smokers and in patients with COPD. However, decreasing in the antioxidant capacity and/or increasing in the oxidant capacity either not correlate with spirometric measurements of airway obstruction in smokers or in patients with COPD were observed. We concluded that the use of cigarette increased oxidative stress by causing plasma lipid peroxidation and imbalance in erythrocyte antioxidant capacity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15143384

Source DB:  PubMed          Journal:  Tuberk Toraks        ISSN: 0494-1373


  4 in total

Review 1.  Pathogenesis of inflammation and repair in advanced COPD.

Authors:  William D Cornwell; Victor Kim; Changcheng Song; Thomas J Rogers
Journal:  Semin Respir Crit Care Med       Date:  2010-05-21       Impact factor: 3.119

2.  Local and systemic oxidative stress status in chronic obstructive pulmonary disease patients.

Authors:  Mian Zeng; Yue Li; Yujie Jiang; Guifang Lu; Xiaomei Huang; Kaipan Guan
Journal:  Can Respir J       Date:  2013 Jan-Feb       Impact factor: 2.409

3.  Plasma oxidant-antioxidant status in different respiratory disorders.

Authors:  Raghunath R Rai; Madhavi S Phadke
Journal:  Indian J Clin Biochem       Date:  2006-09

4.  Expression of nuclear factor erythroid-2-related factor 2, broad complex-tramtrack-bric a brac and Cap'n'collar homology 1 and γ-glutamic acid cysteine synthase in peripheral blood of patients with chronic obstructive pulmonary disease and its clinical significance.

Authors:  Dongrong Li; Ding Sun; Yehan Zhu
Journal:  Exp Ther Med       Date:  2021-03-22       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.